Cargando…
Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis
Cardiovascular disease (CVD) is a global public health issue due to its high morbidity, mortality, and economic impact. The implementation of innovative therapeutic alternatives for CVD is urgently required. Specialized proresolving lipid mediators (SPMs) are bioactive compounds derived from ω-3 and...
Autores principales: | Salazar, Juan, Pirela, Daniela, Nava, Manuel, Castro, Ana, Angarita, Lissé, Parra, Heliana, Durán-Agüero, Samuel, Rojas-Gómez, Diana Marcela, Galbán, Néstor, Añez, Roberto, Chacín, Maricarmen, Diaz, Andrea, Villasmil, Nelson, De Sanctis, Juan Bautista, Bermúdez, Valmore |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955102/ https://www.ncbi.nlm.nih.gov/pubmed/35328553 http://dx.doi.org/10.3390/ijms23063133 |
Ejemplares similares
-
Metabolic Syndrome: Is It Time to Add the Central Nervous System?
por: Rojas, Milagros, et al.
Publicado: (2021) -
Lipid Accumulation Product Is More Related to Insulin Resistance than the Visceral Adiposity Index in the Maracaibo City Population, Venezuela
por: Bermúdez, Valmore, et al.
Publicado: (2021) -
Metabolic Reprogramming in Cancer Cells: Emerging Molecular Mechanisms and Novel Therapeutic Approaches
por: Navarro, Carla, et al.
Publicado: (2022) -
Microbiota and Diabetes Mellitus: Role of Lipid Mediators
por: Salazar, Juan, et al.
Publicado: (2020) -
The Role of Specialized Pro-Resolving Lipid Mediators in Inflammation-Induced Carcinogenesis
por: Torres, Wheeler, et al.
Publicado: (2023)